Chen's penetrating-suture technique for pancreaticojejunostomy following pancreaticoduodenectomy.
Chen’s Penetrating-Suture technique
Pancreaticoduodenectomy
Postoperative pancreatic fistula
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
29 May 2023
29 May 2023
Historique:
received:
24
07
2022
accepted:
23
05
2023
medline:
31
5
2023
pubmed:
30
5
2023
entrez:
29
5
2023
Statut:
epublish
Résumé
Postoperative pancreatic fistula (POPF) is the most serious complication and the main reason for morbidity and mortality after pancreaticoduodenectomy (PD). Currently, there exists no flawless pancreaticojejunal anastomosis approach. We presents a new approach called Chen's penetrating-suture technique for pancreaticojejunostomy (PPJ), which involves end-to-side pancreaticojejunostomy by suture penetrating the full-thickness of the pancreas and jejunum, and evaluates its safety and efficacy. To assess this new approach, between May 2006 and July 2018, 193 consecutive patients who accepted the new Chen's Penetrating-Suture technique after a PD were enrolled in this study. Postoperative morbidity and mortality were evaluated. All cases recovered well after PD. The median operative time was 256 (range 208-352) min, with a median time of 12 (range 8-25) min for performing pancreaticojejunostomy. Postoperative morbidity was 19.7% (38/193) and mortality was zero. The POPF rate was 4.7% (9/193) for Grade A, 1.0% (2/193) for Grade B, and no Grade C cases and one urinary tract infection. PPJ is a simple, safe, and reliable technique with ideal postoperative clinical results.
Sections du résumé
BACKGROUND
BACKGROUND
Postoperative pancreatic fistula (POPF) is the most serious complication and the main reason for morbidity and mortality after pancreaticoduodenectomy (PD). Currently, there exists no flawless pancreaticojejunal anastomosis approach. We presents a new approach called Chen's penetrating-suture technique for pancreaticojejunostomy (PPJ), which involves end-to-side pancreaticojejunostomy by suture penetrating the full-thickness of the pancreas and jejunum, and evaluates its safety and efficacy.
METHODS
METHODS
To assess this new approach, between May 2006 and July 2018, 193 consecutive patients who accepted the new Chen's Penetrating-Suture technique after a PD were enrolled in this study. Postoperative morbidity and mortality were evaluated.
RESULTS
RESULTS
All cases recovered well after PD. The median operative time was 256 (range 208-352) min, with a median time of 12 (range 8-25) min for performing pancreaticojejunostomy. Postoperative morbidity was 19.7% (38/193) and mortality was zero. The POPF rate was 4.7% (9/193) for Grade A, 1.0% (2/193) for Grade B, and no Grade C cases and one urinary tract infection.
CONCLUSION
CONCLUSIONS
PPJ is a simple, safe, and reliable technique with ideal postoperative clinical results.
Identifiants
pubmed: 37248522
doi: 10.1186/s12893-023-02054-y
pii: 10.1186/s12893-023-02054-y
pmc: PMC10228121
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
146Informations de copyright
© 2023. The Author(s).
Références
Br J Surg. 2018 Jan;105(1):48-57
pubmed: 29265404
Langenbecks Arch Surg. 2014 Oct;399(7):811-24
pubmed: 24962147
J Gastrointest Surg. 2010 Apr;14(4):705-10
pubmed: 20054660
Gastroenterol Res Pract. 2020 Jul 30;2020:8914367
pubmed: 32802047
J Laparoendosc Adv Surg Tech A. 2017 Nov;27(11):1185-1191
pubmed: 28609220
HPB (Oxford). 2017 Jun;19(6):515-524
pubmed: 28202218
Asian J Surg. 2021 Jan;44(1):143-146
pubmed: 32409242
Pancreatology. 2017 May - Jun;17(3):497-503
pubmed: 28411019
JAMA Surg. 2020 Apr 1;155(4):313-321
pubmed: 32101272
Hepatogastroenterology. 2011 Nov-Dec;58(112):2132-9
pubmed: 22024085
Ann Surg Oncol. 2017 Jun;24(6):1714-1721
pubmed: 28058551
Lancet Oncol. 2013 Jun;14(7):655-62
pubmed: 23643139
J Surg Res. 2018 Nov;231:304-308
pubmed: 30278945
Lancet Oncol. 2013 Jun;14(7):573-5
pubmed: 23643140
J Am Coll Surg. 2015 May;220(5):e71-7
pubmed: 25840535
Ann Surg. 2006 Jul;244(1):10-5
pubmed: 16794383
Surgery. 2015 Nov;158(5):1211-8
pubmed: 26036878
J Surg Res. 2020 Feb;246:315-324
pubmed: 29754962
Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):67-72
pubmed: 30413347
World J Gastrointest Oncol. 2014 Sep 15;6(9):369-76
pubmed: 25232462
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
Surg Clin North Am. 2021 Oct;101(5):865-874
pubmed: 34537148
Dig Surg. 2017;34(4):265-280
pubmed: 28095392
Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):797-806
pubmed: 31282769
Ann Hepatobiliary Pancreat Surg. 2017 Feb;21(1):39-47
pubmed: 28317044
Int J Surg. 2016 Dec;36(Pt A):240-247
pubmed: 27826046
Anticancer Res. 2019 Jan;39(1):499-504
pubmed: 30591501
J Surg Res. 2015 Feb;193(2):590-7
pubmed: 25175768